TEVA Trademark

Trademark Overview

On Wednesday, September 23, 2020, a trademark application was filed for TEVA with the United States Patent and Trademark Office. The USPTO has given the TEVA trademark a serial number of 90203458. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 17, 2024. This trademark is owned by Teva Pharmaceutical Industries Ltd.. The TEVA trademark is filed in the Advertising, Business and Retail Services category with the following description:

Business and marketing research, all in the field of pharmaceuticals
teva

General Information

Serial Number90203458
Word MarkTEVA
Filing DateWednesday, September 23, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 17, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 16, 2021

Trademark Statements

Goods and ServicesBusiness and marketing research, all in the field of pharmaceuticals
Translation of Words in MarkThe English translation of the word "TEVA" in the mark is "nature".

Classification Information

International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateSaturday, October 31, 2020
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTeva Pharmaceutical Industries Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressTel Aviv 6944020
IL
Party NameTeva Pharmaceutical Industries Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressJerusalem 91010
IL

Trademark Events

Event DateEvent Description
Saturday, October 31, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 26, 2020NEW APPLICATION ENTERED
Friday, February 5, 2021ASSIGNED TO EXAMINER
Wednesday, February 10, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, February 10, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, February 10, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 10, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, February 10, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 16, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 16, 2021PUBLISHED FOR OPPOSITION
Tuesday, May 11, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 5, 2021SOU TEAS EXTENSION RECEIVED
Friday, November 5, 2021SOU EXTENSION 1 FILED
Friday, November 5, 2021SOU EXTENSION 1 GRANTED
Tuesday, November 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 10, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, May 10, 2022SOU EXTENSION 2 FILED
Tuesday, May 10, 2022SOU EXTENSION 2 GRANTED
Thursday, May 12, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 4, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 28, 2023SOU TEAS EXTENSION RECEIVED
Friday, April 28, 2023SOU EXTENSION 4 FILED
Friday, April 28, 2023SOU EXTENSION 4 GRANTED
Tuesday, May 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 1, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, November 1, 2023SOU EXTENSION 5 FILED
Tuesday, November 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 7, 2023SOU EXTENSION 5 GRANTED
Wednesday, November 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 17, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, November 2, 2022SOU EXTENSION 3 GRANTED
Wednesday, November 2, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, November 2, 2022SOU EXTENSION 3 FILED

Related Keywords

teva pharmaceuticals field research marketing business